Belgium’s food safety agency AFSCA-FAVV has ordered Ferrero to suspend production at its plant in Arlon, Belgium due to a link that has been confirmed between more than a hundred cases of salmonella and Kinder chocolate production.
According to AFSCA-FAVV, the decision to temporarily close the plant was taken after finding the information from Ferrero to be incomplete.
Ferrero, the Italian chocolate giant, canceled a number of its Kinder products last week owing to salmonella concerns.
The tainted chocolate was made at Ferrero's Arlon plant, where salmonella was discovered in a filter in December.
According to the Food Standards Agency in the United Kingdom, at least 63 instances of salmonella have been connected to Kinder products, with the majority of the cases occurring in children under the age of five.
Other countries affected by recalls included the US and several European states.
Ferrero acknowledged internal inefficiencies that caused delays in retrieving and sharing information promptly.
Ferrero revealed that the plant would only reopen once certified by the authorities.


US-Mexico USMCA Talks Advance as Auto Rules Remain Major Sticking Point
Canada Vows Trade Fight as Trump Imposes 50% Tariffs
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Wistron Opens $700M Texas AI Factory to Build Nvidia GB300 Superchips
RFK Jr. Spokesman Resigns Over Trump Administration’s Flavored E-Cigarette Policy
Brent Oil Holds Above $100 as Red Sea Attacks, Iran Conflict Threaten Global Supply
Australia ASIC Tightens Auditor Oversight After KPMG Leak Scandal
Super Micro Computer Stock Jumps 20% After Record AI Orders and Margin Surge
Japan CPI Rises in June, but Core Inflation Stays Below BOJ’s 2% Target
Scandinavian Tobacco Group Sells BREAK and Moro Brands to Japan Tobacco for €176 Million
Japan’s Nikkei Slides Over 2% as Alphabet Selloff Sparks AI Spending Concerns
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
European Stocks Slip as Earnings, UK Inflation and ECB Decision Keep Investors on Edge 



